Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

NCT07717892 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

468

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: Solriamfetol Dose A
DRUG: Solriamfetol Dose B
DRUG: Placebo

Sponsor

Axsome Therapeutics, Inc.